Clinical trial

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC +…

NCT00296686 · New York State Psychiatric Institute, Other · Terminated

Key facts

NCT number NCT00296686
Title Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
Official title A Pilot Study of Treatment for Refractory Depression With Sequential Trials of Tranylcypromine, Tranylcypromine Plus Dextroamphetamine, Tranylcypromine Plus Triiodothyronine.
Lead sponsor New York State Psychiatric Institute, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Major Depression
Intervention type Drug
Interventions Tranylcypromine, Dextroamphetamine, Triiodothyronine
Enrollment 31
Start date Sep 1, 2001
Primary completion Aug 1, 2006
Completion Aug 1, 2006
First posted Feb 27, 2006
Last update posted Apr 27, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies